Cargando…

Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions

SIMPLE SUMMARY: This review article aims in describing the origins of chondrosarcoma radiation-resistance and proposes several potential solutions in order to improve the treatment, in regard with tumor grade and characteristics. ABSTRACT: Chondrosarcoma is a malignant cartilaginous tumor that is pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Antoine, Tudor, Mihaela, Montanari, Juliette, Commenchail, Kevin, Savu, Diana Iulia, Lesueur, Paul, Chevalier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093143/
https://www.ncbi.nlm.nih.gov/pubmed/37046623
http://dx.doi.org/10.3390/cancers15071962
Descripción
Sumario:SIMPLE SUMMARY: This review article aims in describing the origins of chondrosarcoma radiation-resistance and proposes several potential solutions in order to improve the treatment, in regard with tumor grade and characteristics. ABSTRACT: Chondrosarcoma is a malignant cartilaginous tumor that is particularly chemoresistant and radioresistant to X-rays. The first line of treatment is surgery, though this is almost impossible in some specific locations. Such resistances can be explained by the particular composition of the tumor, which develops within a dense cartilaginous matrix, producing a resistant area where the oxygen tension is very low. This microenvironment forces the cells to adapt and dedifferentiate into cancer stem cells, which are described to be more resistant to conventional treatments. One of the main avenues considered to treat this type of tumor is hadrontherapy, in particular for its ballistic properties but also its greater biological effectiveness against tumor cells. In this review, we describe the different forms of chondrosarcoma resistance and how hadrontherapy, combined with other treatments involving targeted inhibitors, could help to better treat high-grade chondrosarcoma.